0 724

Cited 21 times in

Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases From Lung Adenocarcinoma: Early Response and Dosimetric Evaluation.

DC Field Value Language
dc.contributor.author김준원-
dc.contributor.author김혜련-
dc.contributor.author서양권-
dc.contributor.author이창걸-
dc.contributor.author조병철-
dc.contributor.author조재호-
dc.contributor.author최치환-
dc.date.accessioned2017-02-24T03:23:35Z-
dc.date.available2017-02-24T03:23:35Z-
dc.date.issued2016-
dc.identifier.issn1533-0346-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/146333-
dc.description.abstractIn this study, the volume response and treatment outcome after hippocampus-sparing whole-brain radiotherapy (HS-WBRT) with simultaneous integrated boost (SIB) using tomotherapy were evaluated. Patients with primary lung adenocarcinoma and multiple brain metastases who had a Karnofsky performance status ≥ 70 and exhibited well-controlled extracranial disease were treated. The prescribed dose was administered in 10 to 14 fractions as 25 to 28 Gy to whole-brain parenchyma, as 40 to 48 Gy to the gross metastatic lesion, and as 30 to 42 Gy to a 5-mm margin to the metastatic lesion. Double-dose gadolinium contrast-enhanced magnetic resonance imaging at 1-mm slice thickness was performed before treatment and at 1, 4, and 7 months post-treatment. The tumor volume reduction ratio was calculated for each follow-up. Between July 2011 and September 2012, 11 patients with 70 lesions were included in this analysis. The median number of lesions per patient was 4 (range, 2-15). The median initial tumor volume was 0.235 cm(3) (range, 0.020-10.140 cm(3)). The treatment plans were evaluated regarding conformation number (CN), target coverage (TC), and homogeneity index (HI). The median follow-up duration was 14 months (range, 3-25 months) and the 1-year intracranial control rate was 67%. The tumor volume reduction was most prominent during the first month with a median reduction rate of 0.717 (range, -0.190 to 1.000). Complete remission was seen in 22 (33%) lesions, and 45 (64%) lesions showed more than 65% reduction in tumor volume. The CN, TC, and HI values were comparable to that of previous studies, and the mean hippocampal dose was 13.65 Gy. No treatment breaks or ≥ G3 acute toxicities were observed during or after treatment. The HS-WBRT with SIB in patients with multiple brain metastases was effective and feasible for volume reduction and showed excellent intracranial control.-
dc.description.statementOfResponsibilityrestriction-
dc.format.extent122~129-
dc.languageEnglish-
dc.publisherSAGE-
dc.relation.isPartOfTECHNOLOGY IN CANCER RESEARCH & TREATMENT-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdenocarcinoma/mortality-
dc.subject.MESHAdenocarcinoma/radiotherapy*-
dc.subject.MESHAdenocarcinoma/secondary-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHAged, 80 and over-
dc.subject.MESHBrain Neoplasms/mortality-
dc.subject.MESHBrain Neoplasms/radiotherapy*-
dc.subject.MESHBrain Neoplasms/secondary-
dc.subject.MESHDose Fractionation-
dc.subject.MESHDose-Response Relationship, Radiation-
dc.subject.MESHFemale-
dc.subject.MESHHippocampus/pathology-
dc.subject.MESHHumans-
dc.subject.MESHKaplan-Meier Estimate-
dc.subject.MESHLung Neoplasms/mortality-
dc.subject.MESHLung Neoplasms/pathology-
dc.subject.MESHLung Neoplasms/radiotherapy*-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHOrgan Sparing Treatments-
dc.subject.MESHRadiotherapy Planning, Computer-Assisted-
dc.subject.MESHRetrospective Studies-
dc.subject.MESHTreatment Outcome-
dc.subject.MESHTumor Burden/radiation effects-
dc.titleHippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases From Lung Adenocarcinoma: Early Response and Dosimetric Evaluation.-
dc.typeArticle-
dc.publisher.locationUnited States-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Radiation Oncology-
dc.contributor.googleauthorKyung Hwan Kim-
dc.contributor.googleauthorByoung Chul Cho-
dc.contributor.googleauthorChang Geol Lee-
dc.contributor.googleauthorHye Ryun Kim-
dc.contributor.googleauthorYang Gun Suh-
dc.contributor.googleauthorJun Won Kim-
dc.contributor.googleauthorChihwan Choi-
dc.contributor.googleauthorJong Geal Baek-
dc.contributor.googleauthorJaeho Cho-
dc.identifier.doi10.1177/1533034614566993-
dc.contributor.localIdA00958-
dc.contributor.localIdA01166-
dc.contributor.localIdA01891-
dc.contributor.localIdA03240-
dc.contributor.localIdA03822-
dc.contributor.localIdA03901-
dc.contributor.localIdA04203-
dc.relation.journalcodeJ02714-
dc.identifier.eissn1533-0338-
dc.identifier.pmid25601853-
dc.identifier.urlhttp://tct.sagepub.com/content/15/1/122.long-
dc.subject.keywordbrain metastasis-
dc.subject.keywordhippocampus-
dc.subject.keywordlung adenocarcinoma-
dc.subject.keywordradiotherapy-
dc.subject.keywordtumor volume-
dc.contributor.alternativeNameKim, Jun Won-
dc.contributor.alternativeNameKim, Hye Ryun-
dc.contributor.alternativeNameSuh, Yang Gun-
dc.contributor.alternativeNameLee, Chang Geol-
dc.contributor.alternativeNameCho, Byoung Chul-
dc.contributor.alternativeNameCho, Jae Ho-
dc.contributor.alternativeNameChoi, Chi Hwan-
dc.contributor.affiliatedAuthorKim, Jun Won-
dc.contributor.affiliatedAuthorKim, Hye Ryun-
dc.contributor.affiliatedAuthorSuh, Yang Gun-
dc.contributor.affiliatedAuthorLee, Chang Geol-
dc.contributor.affiliatedAuthorCho, Byoung Chul-
dc.contributor.affiliatedAuthorCho, Jae Ho-
dc.contributor.affiliatedAuthorChoi, Chi Hwan-
dc.citation.volume15-
dc.citation.number1-
dc.citation.startPage122-
dc.citation.endPage129-
dc.identifier.bibliographicCitationTECHNOLOGY IN CANCER RESEARCH & TREATMENT, Vol.15(1) : 122-129, 2016-
dc.date.modified2017-02-24-
dc.identifier.rimsid53140-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.